The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and ...

To reduce the burden of anemia, health officials need a better picture of the disease's global impact, an understanding made viable by a portable and affordable way to analyze blood. Researchers have ...

TEL AVIV (Reuters) - Israel's Sight Diagnostics said on Wednesday it raised $71 million in private funding to expand sales of its finger-prick blood analyzer and support research and development. Koch ...

Advances in controls and networks combined with components that pack more punch have opened the door to more-precise, durable, and economical pneumatic systems. Miniature CTS diaphragm pumps and ...

Hematology analyzers have revolutionised clinical diagnostics by automating the complete blood count (CBC) and cell differentiation processes. These instruments integrate advanced optical, electrical, ...

TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch ...

Once outside the body, stored blood begins degrading until, by day 42, they're no longer usable. Until now, assessing its quality has required laborious microscopic examination by human experts. A new ...